Head to Head: Should intraductal component of invasive prostate cancer be graded?

The reporting of intraductal carcinoma of the prostate (IDCP) is controversial with conflicting recommendations recently published by the International Society of Urological Pathology (ISUP) and the Genitourinary Pathology Society (GUPS).